Novartis

Novartis CEO's Dilemma: Is $475,000 Too Much For A Leukemia Breakthrough? Or Is It Not Enough?
Forbes
Wed, 08/30/17 - 11:53 pm
Novartis
CAR-T
drug pricing
FDA
acute lymphoblastic leukemia
Kymriah
Joe Jimenez
Novartis Wins Historic FDA Nod, Prices CAR-T For Leukemia at $475,000
Xconomy
Wed, 08/30/17 - 11:48 pm
Novartis
FDA
CAR-T
drug pricing
Kymriah
acute lymphoblastic leukemia
ESC: Novartis faces an uphill battle turning niche drug Ilaris into a cardio blockbuster
Fierce Pharma
Tue, 08/29/17 - 11:05 am
Novartis
Ilaris
Novartis shares slip after mixed heart drug data
Yahoo/Reuters
Mon, 08/28/17 - 09:33 am
Novartis
canakinumab
Ilaris
cardiovascular disease
Best Pharma Stocks Based on R&D Spending
Motley Fool
Mon, 08/28/17 - 09:27 am
R&D
pharma stocks
Roche
Novartis
Pfizer
JNJ
Merck
Novartis Drug May Be A New Way To Prevent Heart Attacks -- And Perhaps Cancer, Too
Forbes
Sun, 08/27/17 - 05:52 pm
Novartis
inflammation
heart attacks
Illaris
Pharma Stocks That Could Move On New Data
Barron's
Sat, 08/26/17 - 07:36 pm
pharma stocks
AbbVie
Bayer
Novartis
Bristol-Myers Squibb
Eli Lilly
European Society of Cardiology
Novartis returns to the discount aisle, buys Xoma’s failed PhIII drug for $31M
Endpoints
Fri, 08/25/17 - 09:53 am
Novartis
Xoma
M&A
gevokizumab
cardiovascular disease
Can Novartis' Kisqali beat Pfizer's market-leading Ibrance to reimbursement in England?
Fierce Pharma
Thu, 08/24/17 - 05:11 pm
Novartis
Kisqali
Pfizer
Ibrance
reimbursement
breast cancer
AmerisourceBergen-owned specialty pharmacy to pay $13.4M to settle kickback allegations
Bizjournals.com
Thu, 08/24/17 - 11:28 am
AmerisourceBergen
kickbacks
False Claims Act
Novartis
Exjade
Meet Bertrand Bodson, Novartis’ new global digital strategy maestro for all things Big Pharma
Endpoints
Thu, 08/24/17 - 10:03 am
Novartis
digital pharma
Big Pharma
Profit finally in sight for gene therapy specialist Oxford Bio
Yahoo/Reuters
Wed, 08/23/17 - 10:07 pm
gene therapy
Oxford BioMedica
CTL019
Novartis
New CAR-T drug for leukemia, while effective, is ‘going to cost a fortune’
Stat
Wed, 08/23/17 - 11:41 am
CAR-T
Novartis
drug pricing
CTL019
leukemia
Dr. Reddy's revives ex-Novartis OTC brands with slate of new ad campaigns
Fierce Pharma
Tue, 08/22/17 - 09:44 am
Dr Reddy's
Novartis
OTC
drug ads
Novartis CEO opens door to cancer patient demanding ‘fair’ CAR-T pricing
Fierce Pharma
Tue, 08/22/17 - 12:05 am
Novartis
Pharma CEOs
CAR-T
Joe Jimenez
drug pricing
Novartis Speeds New Anti-Malarial as Older Drug Loses Potency
Bloomberg
Mon, 08/21/17 - 09:43 am
malaria
Novartis
KAF156
Lawmakers dig into 'skyrocketing' MS costs with probe into 7 drugmakers
Fierce Pharma
Thu, 08/17/17 - 11:48 pm
multiple sclerosis
MS
drug pricing
Bayer
Biogen
Merck KGaA
Novartis
Sanofi
Teva Pharmaceutical
Roche
The decade's top 10 patent losses, worth a whopping $915B in lifetime sales
Fierce Pharma
Thu, 08/17/17 - 10:36 am
patents
AbbVie
Humira
Pfizer
Lipitor
Norvasc
GSK
Advair
Sanofi
Lantus
JNJ
Remicade
AstraZeneca
Crestor
Nexium
Amgen
Neulasta
Novartis
Diovan
After a slow start, Novartis finally gains market traction with heart drug Entresto
Fierce Biotech
Tue, 08/15/17 - 11:14 am
Novartis
Entresto
heart failure
Pharma's giants, new and old, tell more tales than their numbers show
Fierce Pharma
Fri, 08/11/17 - 11:16 am
Big Pharma
JNJ
Pfizer
GSK
Roche
Novartis
Sanofi
Bristol-Myers Squibb

Pages